Clinical Trial Update: HEAL-HF: A Cardiac Resynchronization Therapy (CRT) Outcomes Study [Phase 4]

View source ↗

Summary

HEAL-HF is a Phase 4 cardiac resynchronization therapy outcomes study that has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Stereotaxis | Conditions: Heart Failure, Congestive | Phase 4 | Status: TERMINATED